Clinical Trials Browser

Brain Neoplasms, Carcinoma, Renal Cell, Chondrosarcoma, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00003518 2023-06-22

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

Phase 2 Completed

44 enrolled

GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

NCT00003871 2023-06-22

PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer

Phase 2 Completed

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT00005644 2023-06-22

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function

Phase 2 Completed

Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00005847 2023-06-22

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Genitourinary

Prostatic Neoplasms

NCT00004223 2023-06-18

Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer

Phase 2 Completed

Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00077129 2023-06-18

Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer

Phase 2 Completed

22 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003614 2023-06-15

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

Genitourinary

Prostatic Neoplasms

NCT01164228 2023-06-15

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Phase 2 Completed

87 enrolled 11 charts

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00771017 2023-05-25

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT00951535 2023-04-06

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Phase 2 Unknown

251 enrolled

Genitourinary

Prostatic Neoplasms

NCT02225704 2023-04-06

Radium-223 in Combination With Enzalutamide

Phase 2 Completed

45 enrolled

Genitourinary

Prostatic Neoplasms

NCT00450411 2022-06-21

Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy

Phase 2 Completed

100 enrolled 12 charts

Genitourinary

Prostatic Neoplasms

NCT00777491 2022-06-15

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Phase 2 Completed

70 enrolled 18 charts

Genitourinary

Urinary Bladder Neoplasms

NCT01434290 2022-06-09

Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

255 enrolled 15 charts

GenitourinaryOther

Prostatic Neoplasms, Radiation Injuries, Sexual Dysfunction, Physiological

NCT02452554 2022-01-13

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

Phase 2 Completed

62 enrolled 15 charts

CNSGenitourinarySarcoma

Pleuropulmonary blastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Synovial, Neurofibrosarcoma

NCT01566747 2021-12-23

Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5

Phase 2 Completed

43 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00006365 2020-10-22

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

138 enrolled

Genitourinary

Prostatic Neoplasms

NCT01209325 2020-08-11

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

Phase 2 Completed

149 enrolled 31 charts

GastrointestinalGenitourinaryOther neoplasm

Anus Neoplasms, Penile Neoplasms, Precancerous Conditions, HIV Infections, Papillomavirus Infections

NCT00091390 2020-08-10

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 2 Completed

129 enrolled 20 charts

Genitourinary

Prostatic Neoplasms

NCT00025116 2020-04-06

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

40 enrolled

Genitourinary

Prostatic Neoplasms

NCT00528866 2019-04-24

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Phase 2 Completed

80 enrolled 11 charts

Genitourinary

Prostatic Neoplasms

NCT00467051 2018-08-29

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors

Phase 2 Completed

20 enrolled 8 charts

GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Testicular Neoplasms, Carcinoma, Embryonal, Endodermal Sinus Tumor

NCT00058448 2018-06-28

S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)

Phase 2 Terminated

1 enrolled

Genitourinary

Penile Neoplasms